Published in J Immunol on April 01, 1985
H-2-linked control of in vitro gamma interferon production in response to a 32-kilodalton antigen (P32) of Mycobacterium bovis bacillus Calmette-Guérin. Infect Immun (1988) 1.73
Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun (2000) 1.56
Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein. Infect Immun (1998) 1.01
Trypanosomes expressing a mosaic variant surface glycoprotein coat escape early detection by the immune system. Infect Immun (2005) 0.93
The innate interferon gamma response of BALB/c and C57BL/6 mice to in vitro Burkholderia pseudomallei infection. BMC Immunol (2006) 0.91
Resistance to Mycobacterium lepraemurium is correlated with the capacity to generate macrophage activating factor(s) in response to mycobacterial antigens in vitro. Immunology (1986) 0.86
Modulation of infection by gamma interferon treatment following trauma. Infect Immun (1988) 0.85
A strong antigen-specific T-cell response is associated with age and genetically dependent resistance to avian enteric salmonellosis. Infect Immun (2005) 0.84
Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J Immunol (2008) 0.84
IL-27 Signaling Is Crucial for Survival of Mice Infected with African Trypanosomes via Preventing Lethal Effects of CD4+ T Cells and IFN-γ. PLoS Pathog (2015) 0.83
Control of experimental Trypanosoma brucei infections occurs independently of lymphotoxin-alpha induction. Infect Immun (2002) 0.82
Polyclonal B-cell-activating factors produced by spleen cells of mice stimulated with a cell homogenate of Trypanosoma gambiense. Infect Immun (1987) 0.81
Identification of an acute-phase reactant in murine infections with Trypanosoma brucei. Infect Immun (1992) 0.80
Granulocyte-macrophage colony-stimulating activity in the serum of mice stimulated with homogenates of Trypanosoma gambiense. Clin Exp Immunol (1989) 0.77
Distinct Contributions of CD4+ and CD8+ T Cells to Pathogenesis of Trypanosoma brucei Infection in the Context of Gamma Interferon and Interleukin-10. Infect Immun (2015) 0.76
Biological variation among african trypanosomes: I. Clonal expression of virulence is not linked to the variant surface glycoprotein or the variant surface glycoprotein gene telomeric expression site. DNA Cell Biol (2010) 0.76
Interferon Gamma in African Trypanosome Infections: Friends or Foes? Front Immunol (2017) 0.75
Cell Cycle Inhibition To Treat Sleeping Sickness. MBio (2017) 0.75
Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol (1993) 1.92
The immunosuppressive effect of type II mouse interferon preparations on antibody production. Cell Immunol (1977) 1.64
Enhancing effects of gamma interferon on phagocytic cell association with and killing of Trypanosoma cruzi. Infect Immun (1985) 1.62
Depressed interferon gamma production and monocyte HLA-DR expression after severe injury. Arch Surg (1988) 1.53
Natural killer cells in mice treated with 89strontium: normal target-binding cell numbers but inability to kill even after interferon administration. J Immunol (1979) 1.44
Time and dosage dependence of immunoenhancement by murine type II interferon preparations. Cell Immunol (1978) 1.43
Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease. Arthritis Rheum (1981) 1.41
Suppression of cell-mediated immunity in experimental African trypanosomiasis. Infect Immun (1974) 1.40
In vitro production and cellular origin of murine type II interferon. Immunology (1979) 1.39
Resistance to the African trypanosomes is IFN-gamma dependent. J Immunol (1998) 1.38
Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J Immunol (1983) 1.36
Lymphocyte function in experimental African trypanosomiasis. II. Splenic suppressor cell activity. J Immunol (1979) 1.36
Interferon induces natural killer cell blastogenesis in vivo. J Leukoc Biol (1984) 1.30
Effect of treatment of mice with sera containing gamma interferon on the course of infection with Salmonella typhimurium strain LT-2. J Interferon Res (1980) 1.27
T-cell-independent and T-cell-dependent B-cell responses to exposed variant surface glycoprotein epitopes in trypanosome-infected mice. Infect Immun (1990) 1.27
Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J Immunol (1993) 1.25
Lymphocyte function in experimental African trypanosomiasis. I. B cell responses to helper T cell-independent and -dependent antigens. J Immunol (1978) 1.23
Cell wall protein in Bacillus subtilis. J Bacteriol (1977) 1.21
Genetics of resistance to African trypanosomes: role of the H-2 locus in determining resistance to infection with Trypanosoma rhodesiense. Infect Immun (1981) 1.21
IFN-gamma-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell Immunol (1999) 1.19
Norepinephrine as a growth stimulating factor in bacteria--mechanistic studies. Life Sci (2000) 1.16
Development and characterization of Histoplasma capsulatum-reactive murine T-cell lines and clones. Infect Immun (1986) 1.16
Immunobiology of African trypanosomiasis. Cell Immunol (1978) 1.14
Effect of type I and type II interferons on murine thymocyte surface antigen expression: induction or selection? Cell Immunol (1981) 1.11
A randomized prospective clinical trial to determine the efficacy of interferon-gamma in severely injured patients. Am J Surg (1992) 1.07
Characteristics of the splenic suppressor cell--target cell interaction in experimental African trypanosomiasis. Cell Immunol (1980) 1.07
Autoimmunity in experimental Trypanosoma congolense infections of rabbits. Infect Immun (1972) 1.03
Genetics of resistance to the African trypanosomes. III. Variant-specific antibody responses of H-2-compatible resistant and susceptible mice. J Immunol (1984) 1.03
Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein. Infect Immun (1998) 1.01
Characterization of the antiviral activity produced during Trypanosoma cruzi infection and protective effects of exogenous interferon against experimental Chagas' disease. J Parasitol (1982) 1.00
Lymphocyte function in experimental African trypanosomiasis. VI. Parasite-specific immunosuppression. J Immunol (1983) 0.98
Lymphocyte function in experimental african trypanosomiasis: mitogenic effects of trypanosome extracts in vitro. Infect Immun (1976) 0.98
Changes in the immune system during and after spaceflight. Adv Space Biol Med (1997) 0.97
Interferon-gamma treatment increases HLA-DR expression on monocytes in severely injured patients. Clin Exp Immunol (1989) 0.96
Cellular source of interferons in the circulation of mice with delayed hypersensitivity. Infect Immun (1977) 0.96
Cloning of African trypanosomes in mice immunosuppressed by cyclophosphamide treatment. Am J Trop Med Hyg (1982) 0.96
Lymphocyte function in experimental African trypanosomiasis. III. Loss of lymph node cell responsiveness. J Immunol (1980) 0.95
A regulatory role for interferon in immunity. Ann N Y Acad Sci (1979) 0.95
Increased serum levels of an interferon-like activity during the acute period of experimental infection with different strains of Trypanosoma cruzi. Am J Trop Med Hyg (1981) 0.94
Effect of treatment with interferon-gamma and concanavalin A on the course of infection of mice with Salmonella typhimurium strain LT-2. J Interferon Res (1987) 0.94
Incorporation of 3 H-thymidine into PHA-stimulated rabbit peripheral blood lymphocytes. Kinetics of the response. Proc Soc Exp Biol Med (1973) 0.93
Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. J Immunol (1988) 0.93
Role of antibody in the elimination of trypanosomes after DL-alpha-difluoromethylornithine chemotherapy. J Parasitol (1983) 0.93
Effects of spaceflight and PEG-IL-2 on rat physiological and immunological responses. J Appl Physiol (1985) (1999) 0.92
Treatment of murine macrophages with murine interferon-gamma and tumour necrosis factor-alpha enhances uptake and intracellular killing of Pseudomonas aeruginosa. Clin Exp Immunol (1993) 0.92
Serodiagnosis of neosporosis in individual cows and dairy herds: A comparative study of three enzyme-linked immunosorbent assays. Clin Diagn Lab Immunol (1998) 0.92
Lymphocyte function in experimental African trypanosomiasis. IV. Immunosuppression and suppressor cells in the athymic nu/nu mouse. Cell Immunol (1981) 0.91
Antiorthostatic suspension as a model for the effects of spaceflight on the immune system. J Leukoc Biol (1993) 0.91
Morphological changes in Trypanosoma brucei rhodesiense following inhibition of polyamine biosynthesis in vivo. Tissue Cell (1984) 0.90
The effect of tumor necrosis factor-alpha and interferon-gamma on neutrophil function. J Surg Res (1989) 0.90
Variable and conserved structural elements of trypanosome variant surface glycoproteins. Mol Biochem Parasitol (1992) 0.90
Production of alpha interferon in Cowdria ruminantium-infected cattle and its effect on infected endothelial cell cultures. Infect Immun (1994) 0.90
Cytoskeleton-associated antigens from African trypanosomes are recognized by self-reactive antibodies of uninfected mice. Parasitology (1993) 0.88
Inhibited interferon-gamma but normal interleukin-3 production from rats flown on the space shuttle. Aviat Space Environ Med (1987) 0.88
Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. Clin Exp Immunol (1987) 0.87
Independent regulation of B cell responses to surface and subsurface epitopes of African trypanosome variable surface glycoproteins. J Immunol (1988) 0.87
Beta-interferon inhibits cell infection by Trypanosoma cruzi. J Immunol (1984) 0.87
Effects of interferon-alpha/beta and interferon-gamma preparations on phagocytosis by mouse peritoneal macrophages. Scand J Immunol (1984) 0.87
Role of intracellular calcium concentration and protein kinase C activation in IFN-gamma stimulation of U937 cells. J Immunol (1990) 0.86
Trypanosome variant surface glycoproteins are recognized by self-reactive antibodies in uninfected hosts. Infect Immun (1996) 0.86
Inhibition of murine splenic T lymphocyte proliferation by 2-deoxy-D-glucose-induced metabolic stress. J Neuroimmunol (1994) 0.85
Catecholamine enhancement of Aeromonas hydrophila growth. Microb Pathog (1999) 0.85
Modulation of infection by gamma interferon treatment following trauma. Infect Immun (1988) 0.85
The effects of interferon-alpha/beta in a model of rat heart transplantation. J Heart Lung Transplant (1992) 0.84
Tests for antibody- and cell-mediated hypersensitivity to trypanosome antigens in rabbits infected with Trypanosoma congolense. Infect Immun (1972) 0.84
Interferon-gamma and resistance to bacterial infections. APMIS (1993) 0.83
Lymphocyte function in experimental African trypanosomiasis. VII. Loss of antigen-nonspecific suppressor-T-cell activity. Cell Immunol (1984) 0.83
Trypanosoma vivax: courses of infection with three stabilates in inbred mouse strains. Exp Parasitol (1982) 0.83
Genetics of resistance to the African trypanosomes. II. Differences in virulence associated with VSSA expression among clones of Trypanosoma rhodesiense. J Immunol (1983) 0.83
Effects of passive transfer and induction of gamma (type II immune) interferon preparations on the metabolism of diphenylhydantoin by murine cytochrome P-450. J Interferon Res (1982) 0.83
Effect of SLS-2 spaceflight on immunologic parameters of rats. J Appl Physiol (1985) (1996) 0.83
Influence of exercise mode and carbohydrate on the immune response to prolonged exercise. Int J Sport Nutr (1999) 0.82
Treatment of an infected murine macrophage cell line (J774A.1) with interferon-gamma but not tumor necrosis factor-alpha or live Mycobacterium intracellulare alone modulates the expression of adhesion molecules. J Interferon Cytokine Res (1997) 0.82
Immune changes in test animals during spaceflight. J Leukoc Biol (1993) 0.82
Modulation of the human in vitro antibody response by human leukocyte interferon preparations. Cell Immunol (1981) 0.82
Studies on the growth and survival of Staphylococcus aureus in corned beef. J Hyg (Lond) (1983) 0.82
Effects of interferon-gamma and tumor necrosis factor-alpha on macrophage enzyme levels. J Interferon Res (1989) 0.82
Immune enhancement by tumor necrosis factor-alpha improves antibiotic efficacy after hemorrhagic shock. J Trauma (1989) 0.81
The effect of smoke age and dilution on the cytotoxicity of sidestream (passive) smoke. Toxicol Lett (1987) 0.81
Effect of gamma interferon preparations on in vitro phagocytosis and degradation of Escherichia coli by mouse peritoneal macrophages. J Interferon Res (1981) 0.81
Inhibition of interferon, cytokine, and lymphocyte proliferative responses in elite swimmers with altitude exposure. J Interferon Cytokine Res (2000) 0.80
Effect of sidestream and mainstream smoke exposure on in vitro interferon-alpha/beta production by L-929 cells. Cancer Res (1986) 0.79
Effects of interferon-gamma treatment on surgically simulated wound infection in mice. Microb Pathog (1988) 0.79
INduction and production of guinea pig interferon. Methods Enzymol (1981) 0.79
In vivo studies on the cellular source of migration inhibitory factor in mice with delayed hypersensitivity. Infect Immun (1977) 0.79
Modulation of transferrin receptor expression by insulin and granulocyte-macrophage colony stimulating factor in AML-193 leukemic cells. Cancer Lett (1993) 0.79
Effects of social conflict on immune responses and E. coli growth within closed chambers in mice. Physiol Behav (1999) 0.79
Modulation of Klebsiella pneumoniae infection of mice by interferon-gamma. Clin Exp Immunol (1988) 0.79
Effects of 2-deoxy-D-glucose administration on immune parameters in mice. Immunopharmacology (1998) 0.79
Effect of a simulated weightlessness model on the production of rat interferon. J Interferon Res (1982) 0.78
Antiorthostatic suspension stimulates profiles of macrophage activation in mice. Neuroimmunomodulation (1999) 0.78
Trypanosoma vivax: absence of host protein on the surface coat. Exp Parasitol (1981) 0.78
Characterization of a relatively rare class B, type 2 trypanosome variant surface glycoprotein gene. J Parasitol (1998) 0.78
Trypanosoma vivax and immunosuppression. Ann Soc Belg Med Trop (1979) 0.78
Effects of interferon on drug metabolism. Tex Rep Biol Med (1983) 0.78
Effect of nickel sulfide on induction of interleukin-1 and phagocytic activity. Environ Res (1993) 0.78
Genetics of resistance to the African trypanosomes. IV. Resistance of radiation chimeras to Trypanosoma rhodesiense infection. Cell Immunol (1984) 0.78